Andrew Cothrel

About Andrew Cothrel

A unique blending of senior corporate executive roles combined with venture, consulting, and startups experience lets me share perspectives and judgement that help turn a technology, product, patent, know-how, or other R&D output into money and into something useful in a customer\'s hands, by creating a viable business, pursing licensing or partnerships, or seeking exit/asset sale.> Foundation of 20 years in Fortune 100 companies leading large, successful international projects, functions, and businesses, developing and launching multi-$B healthcare/medtech products.> Second-stage career of 18 years (and counting) in startups/consulting/venture with a common thread of commercializing novel & differentiated technology. Employers/clients have spanned giants to start-ups across multiple industries, with emphasis on medical/life sciences, and more recently greentech/cleantech and defense/dual use. With strategy lessons learned from some of the world\'s finest consulting houses and universities, as well as extensive experience in (and bruises from) real-world application of those lessons, I\'m all about bringing innovations to market and driving adoption/growth/exits to create value.Search Words:Innovation; venture; venture studio; venture capital; venture fund; commercialization; operations, financing, commercial, regulatory, technical, organizational, capital formation; entrepreneurial finance; partnerships; collaborations; licensing; startups, spin-outs; competitive assessment; strategy; due diligence; integration; financial management; product development; product-market fit; coaching; mentoring; change management; expert witness; M&A; market characterization; competitive assessment; customer discovery.In-vitro diagnostics; IVD; imaging; point of care; OTC; health IT; life science; research toolsDiabetes; diabesity; heart failure; coagulation; fertility; lymphatic access; NASH; NAFLD; obesity; chronic disease; medical robotics; PKU, phenylketonuriaHuman performance; wearables; orthopedics (total joints, extremities, spine, sports medicine, biologics); patient monitoring; continuous monitoring, aptamers, cardiovascular, respiratory; surgical tools; combination devices; digital biomarkers; emergent care; critical care; trauma; medevac; vascular access; oncology; pediatric; NICU; intraoperative visualization; drug repurposing505(b)(2); FDA; ISO 13485; QMS; quality management; clinical trials; health economics; regulatory; 510(k); CMS; AKS; Stark.

Experience

1. Board Member

   Royal Biologics, Inc

   Dec 2019 — Present

   AR Orthopedic Holdings (Royal Biologics) focuses on developing and offering cutting edge autologous and live cellular solutions for orthopedic (spine) and wound care applications. Internal innovation complemented with strategic acquisitions (and our recent partnership in cold plasma tech!) are positioning Royal as a clear leader in promoting healing in musculoskeletal and regenerative medicine and wound care.

Education

• The Ohio State University

  BSME, Energy conversion, thermo/fluidics

  1982 — 1986

• University of Michigan

  MSE, Biomechanics, Alt. Energy, Technology Management

  1986 — 1987

• London Business School

  Roche Horizons Program

  2000 — 2002

• Cranfield School of Management

  Executive Management Programme (Boehringer Mannheim)

  1997 — 1998

Skills

• Business Process Improvement
• Fda
• Life Sciences
• Lean Manufacturing
• Cross-Functional Team Leadership
• Manufacturing
• Negotiation
• Turnarounds
• Organizational Effectiveness
• R&D
• Venture Capital
• Restructuring
• Public Speaking
• P&L Management
• Change
• Management Consulting
• Leadership
• Organizational Design
• Organizational Change
• Executive Coaching
• Six Sigma
• Biotechnology
• Commercialization
• Team Building
• Product Development
• Technology Transfer
• Business Development
• Organizational Development
• Leadership Development
• Market Research
• Team Leadership
• Diagnostics
• Lifesciences
• Executive Management
• Business Planning
• Operations Management
• Coaching
• Medical Devices
• Business Strategy
• Capital Formation